Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
BAAR, Switzerland--(BUSINESS WIRE)--Feb 26, 2026-- Novocure (NASDAQ: NVCR) today reported financial results for the quarter and full year ended December 31, 2025. Novocure is a global oncology company working to extend survival in some of the most …